Medulloblastoma other imaging findings

Medulloblastoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Medulloblastoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case studies
Case #1
Medulloblastoma other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Medulloblastoma other imaging findings All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Medulloblastoma other imaging findings
CDC on Medulloblastoma other imaging findings
Medulloblastoma other imaging findings in the news
Blogs on Medulloblastoma other imaging findings
Directions to Hospitals Treating Medulloblastoma
Risk calculators and risk factors for Medulloblastoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Magnetic resonance (MR) spectroscopy study for medulloblastoma demonstrates an elevated choline level and a reduced N-acetyl aspartate level. MR spectroscopy study also demonstrates a peak in taurine level.

Other Imaging Findings

Magnetic resonance spectroscopy

• MR spectroscopy imaging may distinguish medulloblastoma from other differential diagnosis. Features include:

• Elevated choline level
• Significantly elevated taurine level
• Reduced N-acetyl aspartate level